Loading...
Header Logo
Keywords
Last Name
KP Region

Jason M Glanz, PhD

TitleSenior Investigator
InstitutionKaiser Permanente Colorado
DepartmentInstitute for Health Research
ORCID ORCID Icon0000-0002-1950-7034 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Jason M. Glanz, PhD, is a Senior Investigator at the Institute for Health Research. Dr. Glanz's research focuses on vaccine safety, vaccine acceptance, substance abuse, and epidemiological methods.

    Dr. Glanz earned his Master of Science degree in biostatistics from the University of Massachusetts Amherst and completed his doctoral training in epidemiology at the Colorado School of Public Health. He is a co-principal investigator for the Vaccine Safety Datalink (VSD), a nationwide Centers for Disease Control and Prevention-funded project that examines the safety of vaccines and leads research efforts to develop risk communication tools to reduce parental vaccination concerns. He is also co-leading a large randomized pragmatic trial examining the impact and safety of co-dispensing the overdose reversing medication naloxone with opioid prescriptions.

    Dr. Glanz is an Associate Clinical Professor of Epidemiology in the Department of Epidemiology at the University of Colorado School of Public Health.

    Collapse Research 
    Collapse research activities and funding
    5R01HD079457-05     (Dempsey/Glanz)May 5, 2014 - Mar 31, 2020
    NIH/NICHD
    The REDIVAC Study - Reducing Delay in Vaccination of Children Study
    Role: Principal Investigator

    200-2012-53582 (TO 0009)     (Daley)Sep 25, 2015 - Sep 24, 2019
    CDC
    Vaccine Safety Datalink (VSD) Under-Vaccinated Children
    Role: Co-Principal Investigator

    5R01DA042059-04     (Binswanger/Glanz)Aug 1, 2016 - Apr 30, 2021
    NIH/NIDA
    The Safety and Impact of Expanded Access to Naloxone in Health Systems
    Role: Principal Investigator

    1U01CE002791-05     (Binswanger/Glanz)Sep 1, 2017 - Aug 31, 2020
    CDC/NCIPC
    Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever
    Role: Principal Investigator

    200-2012-53582 (10)     (Glanz)Sep 28, 2017 - Sep 27, 2022
    CDC/NCEZID
    VSD Infrastructure
    Role: Principal Investigator

    200-2012-53582     (Daley)Sep 20, 2018 - Sep 19, 2020
    CDC/NCEZID
    Vaccine Safety Datalink (VSD) Flu Survey
    Role: Co-Principal Investigator

    200-2012-53582     (Glanz)Sep 28, 2018 - Sep 19, 2022
    CDC/NCEZID
    Vaccine Safety Datalink (VSD) Shingrix
    Role: Principal Investigator

    3UG1DA0403144-05S5     (Campbell)Feb 15, 2019 - May 31, 2020
    NIH/NIDA
    Determining the Optimal Duration of Buprenorphine Treatment to Reduce the Risk of Relapse, Overdose, and Mortality"
    Role: Co-Principal Investigator

    1R01DA047537-01     (Binswanger/Glanz)Mar 15, 2019 - Dec 31, 2022
    NIH/NIDA
    Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems
    Role: Principal Investigator

    R01DA042059-04S2     (Binswanger/Glanz)May 1, 2019 - Apr 30, 2020
    NIH/NIDA
    The Safety and Impact of Expanded Access to Naloxone in Health Systems
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Glanz JM, Binswanger IA, Shetterly SM, Narwaney KJ, Xu S. Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy. JAMA Netw Open. 2019 Apr 05; 2(4):e192613. PMID: 31002325.
      View in: PubMed
    2. Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019 Mar 15; 1-9. PMID: 30875477.
      View in: PubMed
    3. Xu S, Newcomer SR, Kulldorff M, Daley MF, Fireman B, Glanz JM. Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule. Vaccine. 2019 Feb 28; 37(10):1325-1331. PMID: 30709727.
      View in: PubMed
    4. Shoup JA, Narwaney KJ, Wagner NM, Kraus CR, Gleason KS, Albright K, Glanz JM. Social Media Vaccine Websites: A Comparative Analysis of Public and Moderated Websites. Health Educ Behav. 2018 Dec 29; 1090198118818253. PMID: 30596265.
      View in: PubMed
    5. McClure DL, Jacobsen SJ, Klein NP, Naleway AL, Kharbanda EO, Glanz JM, Jackson LA, Weintraub ES, McLean HQ. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders. Vaccine. 2019 Jan 03; 37(1):76-79. PMID: 30478005.
      View in: PubMed
    6. Binswanger IA, Joseph N, Hanratty R, Gardner EM, Durfee J, Narwaney KJ, Breslin K, Mueller SR, Glanz JM. Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care. Mayo Clin Proc Innov Qual Outcomes. 2018 Dec; 2(4):309-316. PMID: 30560232.
      View in: PubMed
    7. Binswanger IA, Glanz JM. Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. Drug Saf. 2018 10; 41(10):979-980. PMID: 30073490.
      View in: PubMed
    8. Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. Pharmacoepidemiol Drug Saf. 2018 Aug; 27(8):921-925. PMID: 29862604.
      View in: PubMed
    9. Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM. Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample. Biom J. 2018 07; 60(4):748-760. PMID: 29768667.
      View in: PubMed
    10. Daley MF, Narwaney KJ, Shoup JA, Wagner NM, Glanz JM. Addressing Parents' Vaccine Concerns: A Randomized Trial of a Social Media Intervention. Am J Prev Med. 2018 Jul; 55(1):44-54. PMID: 29773490.
      View in: PubMed
    11. Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, McLean HQ, Klein NP, Weintraub ES, McNeil MM, Glanz JM. Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule. Acad Pediatr. 2018 Sep - Oct; 18(7):754-762. PMID: 29604461.
      View in: PubMed
    12. Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age. JAMA. 2018 03 06; 319(9):906-913. PMID: 29509866.
      View in: PubMed
    13. Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES. Infant Hospitalizations and Mortality After Maternal Vaccination. Pediatrics. 2018 03; 141(3). PMID: 29463582.
      View in: PubMed
    14. Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay DK. Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizations. Influenza Other Respir Viruses. 2018 01; 12(1):122-131. PMID: 28960732.
      View in: PubMed
    15. Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M. Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines. Pharmacoepidemiol Drug Saf. 2018 Apr; 27(4):405-412. PMID: 29441647.
      View in: PubMed
    16. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 Oct; 33(10):1646-1653. PMID: 29380216.
      View in: PubMed
    17. Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM. Bias from outcome misclassification in immunization schedule safety research. Pharmacoepidemiol Drug Saf. 2018 Feb; 27(2):221-228. PMID: 29292551.
      View in: PubMed
    18. Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz JM, Jacobsen SJ, Weintraub ES, Klein NP, Gargiullo PM, Fry AM. Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults. BMC Pulm Med. 2017 Dec 16; 17(1):208. PMID: 29246210.
      View in: PubMed
    19. Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2018 Jan; 27(1):59-68. PMID: 29148124.
      View in: PubMed
    20. Glanz JM, Wagner NM, Narwaney KJ, Kraus CR, Shoup JA, Xu S, O'Leary ST, Omer SB, Gleason KS, Daley MF. Web-based Social Media Intervention to Increase Vaccine Acceptance: A Randomized Controlled Trial. Pediatrics. 2017 Dec; 140(6). PMID: 29109107.
      View in: PubMed
    21. McCarthy NL, Sukumaran L, Newcomer S, Glanz J, Daley MF, McClure D, Klein NP, Irving S, Jackson ML, Lewin B, Weintraub E. Patterns of childhood immunization and all-cause mortality. Vaccine. 2017 12 04; 35(48 Pt B):6643-6648. PMID: 29061349.
      View in: PubMed
    22. Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. Vaccine. 2017 09 25; 35(40):5314-5322. PMID: 28917295.
      View in: PubMed
    23. Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA. Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink. Vaccine. 2017 10 13; 35(43):5872-5877. PMID: 28888342.
      View in: PubMed
    24. Daley MF, Glanz JM, Newcomer SR, Jackson ML, Groom HC, Lugg MM, McLean HQ, Klein NP, Weintraub ES, McNeil MM. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule. Vaccine. 2017 04 04; 35(15):1873-1878. PMID: 28285983.
      View in: PubMed
    25. Klein NP, Lewis E, McDonald J, Fireman B, Naleway A, Glanz J, Jackson LA, Donahue JG, Jacobsen SJ, Weintraub E, Baxter R. Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines. Vaccine. 2017 03 14; 35(12):1615-1621. PMID: 28233624.
      View in: PubMed
    26. Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain. J Gen Intern Med. 2017 Mar; 32(3):277-283. PMID: 27798775.
      View in: PubMed
    27. Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29. PMID: 26830300.
      View in: PubMed
    28. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med. 2015 Dec; 30(12):1837-44. PMID: 26055224.
      View in: PubMed
    29. Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine. 2015 Nov 27; 33 Suppl 4:D66-71. PMID: 26615171.
      View in: PubMed
    30. Groom HC, Henninger ML, Smith N, Koppolu P, Cheetham TC, Glanz JM, Hambidge SJ, Jackson LA, Kharbanda EO, Klein NP, McCarthy NL, Nordin JD, Weintraub ES, Naleway AL. Influenza Vaccination During Pregnancy: Influenza Seasons 2002-2012, Vaccine Safety Datalink. Am J Prev Med. 2016 Apr; 50(4):480-488. PMID: 26526159.
      View in: PubMed
    31. Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children. Vaccine. 2015 Nov 27; 33(48):6736-44. PMID: 26518400.
      View in: PubMed
    32. Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine Hesitancy: Causes, Consequences, and a Call to Action. Am J Prev Med. 2015 Dec; 49(6 Suppl 4):S391-8. PMID: 26337116.
      View in: PubMed
    33. Glanz JM, Kraus CR, Daley MF. Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing. PLoS Biol. 2015 Aug; 13(8):e1002227. PMID: 26252770.
      View in: PubMed
    34. Gaskin GL, Glanz JM, Binswanger IA, Anoshiravani A. Immunization Coverage Among Juvenile Justice Detainees. J Correct Health Care. 2015 Jul; 21(3):265-75. PMID: 26084948.
      View in: PubMed
    35. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus. 2015; 36(2):240-53. PMID: 25774771.
      View in: PubMed
    36. Binswanger IA, Glanz JM. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice. Subst Abus. 2015; 36(2):141-3. PMID: 25671706.
      View in: PubMed
    37. Shoup JA, Wagner NM, Kraus CR, Narwaney KJ, Goddard KS, Glanz JM. Development of an interactive social media tool for parents with concerns about vaccines. Health Educ Behav. 2015 Jun; 42(3):302-12. PMID: 25413375.
      View in: PubMed
    38. McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson LA, Omer SB, Jacobsen SJ, DeStefano F. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014 Sep 22; 32(42):5390-8. PMID: 25108215.
      View in: PubMed
    39. Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, Klein NP, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9. PMID: 24843064.
      View in: PubMed
    40. Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24. PMID: 24699471.
      View in: PubMed
    41. Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Craig Cheetham T, Nakasato C, Glanz JM, Hambidge SJ, Davis RL, Klein NP, McCarthy NL, Weintraub E. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med. 2014 Feb; 46(2):150-7. PMID: 24439348.
      View in: PubMed
    42. Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, DeStefano F. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014 Feb 06; 370(6):513-9. PMID: 24422678.
      View in: PubMed
    43. Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, Zeng C, Glanz J. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 May; 56(3):513-25. PMID: 24402780.
      View in: PubMed
    44. McClure DL, Raebel MA, Yih WK, Shoaibi A, Mullersman JE, Anderson-Smits C, Glanz JM. Mini-Sentinel methods: framework for assessment of positive results from signal refinement. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):3-8. PMID: 24395545.
      View in: PubMed
    45. Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, Curns AT, Weintraub E, Parashar UD. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis. 2014 Jan; 58(2):173-7. PMID: 24265355.
      View in: PubMed
    46. Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, Lugg MM, Weintraub ES. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. 2013 Nov; 167(11):1060-4. PMID: 24019039.
      View in: PubMed
    47. Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, Xu S. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol. 2013 Dec 15; 178(12):1750-9. PMID: 24327463.
      View in: PubMed
    48. Glanz JM, Wagner NM, Narwaney KJ, Shoup JA, McClure DL, McCormick EV, Daley MF. A mixed methods study of parental vaccine decision making and parent-provider trust. Acad Pediatr. 2013 Sep-Oct; 13(5):481-8. PMID: 24011751.
      View in: PubMed
    49. Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013 Sep 13; 31(40):4293-304. PMID: 23859839.
      View in: PubMed
    50. Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children. Vaccine. 2013 Aug 20; 31(37):3894-8. PMID: 23831326.
      View in: PubMed
    51. McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG, Jackson ML, Lee GM, Glanz J, Baxter R, Lugg MM, Naleway A, Omer SB, Nakasato C, Vazquez-Benitez G, DeStefano F. Mortality rates and cause-of-death patterns in a vaccinated population. Am J Prev Med. 2013 Jul; 45(1):91-97. PMID: 23790993.
      View in: PubMed
    52. Daley MF, Sinaiko AR, Reifler LM, Tavel HM, Glanz JM, Margolis KL, Parker E, Trower NK, Chandra M, Sherwood NE, Adams K, Kharbanda EO, Greenspan LC, Lo JC, O'Connor PJ, Magid DJ. Patterns of care and persistence after incident elevated blood pressure. Pediatrics. 2013 Aug; 132(2):e349-55. PMID: 23821694.
      View in: PubMed
    53. Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, Yih K, Baxter R, Glanz JM, Donahue J, Naleway A, Nordin J, Jacobsen SJ. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013 May 24; 31(22):2578-83. PMID: 23579258.
      View in: PubMed
    54. Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, Weintraub ES. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013 Mar 01; 167(3):274-81. PMID: 23338829.
      View in: PubMed
    55. Xu S, Hambidge SJ, McClure DL, Daley MF, Glanz JM. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Stat Med. 2013 Aug 30; 32(19):3290-9. PMID: 23303643.
      View in: PubMed
    56. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70. PMID: 23294765.
      View in: PubMed
    57. Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, DeStefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, Nordin JD, Belongia EA. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2013 Jan; 121(1):159-65. PMID: 23262941.
      View in: PubMed
    58. Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, Hambidge SJ. Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children. Vaccine. 2013 Feb 04; 31(7):1123-8. PMID: 23261040.
      View in: PubMed
    59. Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2013 Feb; 56(3):315-21. PMID: 23196953.
      View in: PubMed
    60. Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012 Jul; 50 Suppl:S21-9. PMID: 22692254.
      View in: PubMed
    61. Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. Influenza Other Respir Viruses. 2012 Nov; 6(6):e143-51. PMID: 22687171.
      View in: PubMed
    62. McClure DL, Xu S, Weintraub E, Glanz JM. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine. 2012 Jun 08; 30(27):3986-91. PMID: 22531555.
      View in: PubMed
    63. Xu S, Zeng C, Newcomer S, Nelson J, Glanz J. Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies. J Biom Biostat. 2012 Apr 19; Suppl 7:006. PMID: 24707443.
      View in: PubMed
    64. Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14. PMID: 22473362.
      View in: PubMed
    65. Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, Steiner JF. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012; 7:3. PMID: 22966409.
      View in: PubMed
    66. Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012 Feb 08; 307(6):598-604. PMID: 22318281.
      View in: PubMed
    67. O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 2012 Feb; 129(2):248-55. PMID: 22232308.
      View in: PubMed
    68. Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, Shoup JA, Narwaney K, Baggs J, Weintraub E. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics. 2012 Jan; 129(1):e54-9. PMID: 22157132.
      View in: PubMed
    69. Hambidge SJ, Ross C, McClure D, Glanz J. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort. Vaccine. 2011 Oct 26; 29(46):8179-81. PMID: 21930176.
      View in: PubMed
    70. Daley MF, Glanz JM. Straight talk about vaccination. Sci Am. 2011 Sep; 305(3):32, 34. PMID: 21870438.
      View in: PubMed
    71. Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. Arch Pediatr Adolesc Med. 2011 Aug; 165(8):749-55. PMID: 21810637.
      View in: PubMed
    72. Nelson CA, France EK, Shetterly SM, Glanz JM. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection. Pediatr Infect Dis J. 2011 Jul; 30(7):562-5. PMID: 21248657.
      View in: PubMed
    73. Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011 May; 127 Suppl 1:S45-53. PMID: 21502240.
      View in: PubMed
    74. Glanz JM, McClure DL, O'Leary ST, Narwaney KJ, Magid DJ, Daley MF, Hambidge SJ. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine. 2011 Jan 29; 29(5):994-9. PMID: 21145372.
      View in: PubMed
    75. Xu S, Zhang L, Nelson JC, Zeng C, Mullooly J, McClure D, Glanz J. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2011 Mar 30; 30(7):742-52. PMID: 21394750.
      View in: PubMed
    76. Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Hambidge SJ. Parental refusal of varicella vaccination and the associated risk of varicella infection in children. Arch Pediatr Adolesc Med. 2010 Jan; 164(1):66-70. PMID: 20048244.
      View in: PubMed
    77. Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010 Jan; 29(1):1-5. PMID: 19907356.
      View in: PubMed
    78. Greene SK, Kulldorff M, Lewis EM, Li R, Yin R, Weintraub ES, Fireman BH, Lieu TA, Nordin JD, Glanz JM, Baxter R, Jacobsen SJ, Broder KR, Lee GM. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010 Jan 15; 171(2):177-88. PMID: 19965887.
      View in: PubMed
    79. Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM. Risk of immune hemolytic anemia in children following immunization. Vaccine. 2009 Dec 09; 27(52):7394-7. PMID: 19766577.
      View in: PubMed
    80. Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Salmon DA, Hambidge SJ. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics. 2009 Jun; 123(6):1446-51. PMID: 19482753.
      View in: PubMed
    81. Donahue JG, Kieke BA, Yih WK, Berger NR, McCauley JS, Baggs J, Zangwill KM, Baxter R, Eriksen EM, Glanz JM, Hambidge SJ, Klein NP, Lewis EM, Marcy SM, Naleway AL, Nordin JD, Ray P, Belongia EA. Varicella vaccination and ischemic stroke in children: is there an association? Pediatrics. 2009 Feb; 123(2):e228-34. PMID: 19171574.
      View in: PubMed
    82. McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008 Jun 19; 26(26):3341-5. PMID: 18462849.
      View in: PubMed
    83. Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008 Mar; 121(3):e506-12. PMID: 18310170.
      View in: PubMed
    84. France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008 Mar; 121(3):e687-92. PMID: 18310189.
      View in: PubMed
    85. Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006 Oct 25; 296(16):1990-7. PMID: 17062862.
      View in: PubMed
    86. Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006 Aug; 59(8):808-18. PMID: 16828674.
      View in: PubMed
    87. Koester S, Glanz J, Barón A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005 Mar; 9(1):27-39. PMID: 15812611.
      View in: PubMed
    88. France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med. 2004 Nov; 158(11):1031-6. PMID: 15520339.
      View in: PubMed
    89. Koester S, Heimer R, Barón AE, Glanz J, Teng W. Re: "Risk of hepatitis C virus among young adult injection drug users who share injection equipment". Am J Epidemiol. 2003 Feb 15; 157(4):376; author reply 376-8. PMID: 12578809.
      View in: PubMed
    90. Glanz J, Grant B, Monteiro M, Tabakoff B. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism. Alcohol Clin Exp Res. 2002 Jul; 26(7):1047-61. PMID: 12170115.
      View in: PubMed
    91. Hoffman PL, Glanz J, Tabakoff B. Platelet adenylyl cyclase activity as a state or trait marker in alcohol dependence: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcohol Clin Exp Res. 2002 Jul; 26(7):1078-87. PMID: 12170118.
      View in: PubMed
    92. Snell LD, Glanz J, Tabakoff B. Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements. Alcohol Clin Exp Res. 2002 Jul; 26(7):1105-13. PMID: 12170121.
      View in: PubMed
    93. Tabakoff B, Helander A, Conigrave KM, Martinez L, Hoffman PL, Whitfield J, Degenhardt L, Saunders J, Barón A, Glanz J. WHP/ISBRA study on state and trait markers in alcoholism. Alcohol Clin Exp Res. 2001 May; 25(5 Suppl ISBRA):99S-103S. PMID: 11391057.
      View in: PubMed
    94. Ruttenber AJ, Harrison LT, Baron A, McClure D, Glanz J, Quillin R, O'Neill JP, Sullivan L, Campbell J, Nicklas JA. hprt mutant frequencies, nonpulmonary malignancies, and domestic radon exposure: "postmortem" analysis of an interesting hypothesis. Environ Mol Mutagen. 2001; 37(1):7-16. PMID: 11170237.
      View in: PubMed
    Glanz's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2019 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.